| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |